Jeremy L. Davis, M.D.
Dr. Jeremy L. Davis is a surgical oncologist whose research focus is in upper gastrointestinal tract malignancy, including stomach, pancreas and hepatobiliary cancers. He is the principal investigator for trials aimed at elucidating the drivers of metastasis in stomach cancers, including inherited forms of stomach cancer. Dr. Davis also directs the Surgical Oncology Research Fellowship.
Phase II Study Evaluating Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects with Hereditary Diffuse Gastric Cancer SyndromeOpen - Not yet RecruitingNCI Protocol ID NCI-18-C-0141Investigator Jeremy L. Davis, M.D.Share this trial: Referral Contacts
Contact Name Phone Number Maureen Connolly 301-435-5613
Phase II Trial of Heated Intraperitoneal Chemotherapy for Gastric Cancer with Positive Peritoneal CytologyOpen - RecruitingNCI Protocol ID NCI-17-C-0070Investigator Jeremy L. Davis, M.D.
Open - RecruitingNCI Protocol ID NCI-17-C-0044Investigator Jeremy L. Davis, M.D.
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerOpen - RecruitingNCI Protocol ID NCI-17-C-0043Investigator Jeremy L. Davis, M.D.
Tumor, Normal Tissue and Specimens from Patients Undergoing Evaluation or Surgical Resection of Solid TumorsOpen - RecruitingNCI Protocol ID NCI-13-C-0176Investigator Jeremy L. Davis, M.D.
My clinical and research interests are in the treatment of gastric cancer and hepato-pancreato-biliary tumors. We manage gastric and gastroesophageal junction tumors as part of a multi-disciplinary foregut malignancy team of thoracic and general surgical oncologists and medical oncologists. Our clinical program is coordinated with the translational and basic science research efforts within the Branch.
Selected Key Publications
- Ann Surg Oncol. epub: 2016. [ Journal Article ]
β-Catenin activation in fundic gland polyps, gastric cancer and colonic polyps in families afflicted by 'gastric adenocarcinoma and proximal polyposis of the stomach' (GAPPS)..J Clin Pathol. 69(9): 826-833, 2016. [ Journal Article ]
Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review..J Surg Oncol. 115(2): 192-201, 2017. [ Journal Article ]
- Surg Clin North Am. 2017. [ Journal Article ]
- Trials. 12(1): 129, 2011. [ Journal Article ]
Dr. Davis trained in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center with an interest in gastric and hepato-pancreato-biliary tumors. He is board certified in both Complex General Surgical Oncology and General Surgery. Dr. Davis completed his surgical training at Indiana University during which time he dedicated three years as a research fellow in Surgical Oncology and Immunotherapy at NCI.
|Maureen Connolly RN||Research Nurse|
|Stacy Joyce PA-C||Physician Assistant (Contr.)|
|Joanna Lamot||Program Assistant|
|Paul Nolen||Patient Care Coordinator|
|Amynah Pradhan CRNP-F, MSN, RN||Nurse Practitioner|
|Yvonne Shutack||Clinical Research Associate II (Contr.)|